| LLYELI LILLY & Co | 19,877 | $18.3M |
| JNJJOHNSON & JOHNSON | 59,484 | $14.5M |
| ABBVAbbVie Inc. | 40,774 | $8.9M |
| MCKMcKesson Corporation | 9,448 | $8.2M |
| MRKMerck & Co., Inc. | 48,890 | $5.9M |
| ABTABBOTT LABORATORIES | 45,608 | $4.7M |
| NVSNovartis AG | 28,079 | $4.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 15,071 | $4.1M |
| AZNASTRAZENECA PLC | 20,254 | $4.0M |
| AMGNAMGEN INC | 10,083 | $3.5M |
| PMPhilip Morris International Inc | 21,346 | $3.5M |
| GILDGILEAD SCIENCES, INC. | 23,813 | $3.3M |
| CORCencora Inc. | 10,314 | $3.2M |
| PFEPFIZER INC | 103,780 | $2.9M |
| BMYBRISTOL MYERS SQUIBB CO | 38,784 | $2.4M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 5,247 | $2.3M |
| RDYDR REDDYS LABORATORIES LTD | 104,888 | $1.5M |
| NVONovo Nordisk A/S | 36,786 | $1.4M |
| ZTSZoetis Inc. | 10,871 | $1.3M |
| CAHCardinal Health Inc. | 5,769 | $1.2M |
| BIIBBIOGEN INC. | 6,350 | $1.2M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 20,090 | $1.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,199 | $926K |
| GMOptec International, Inc. | 11,293 | $841K |
| IDXXIDEXX LABORATORIES INC /DE | 1,259 | $707K |
| SNYSanofi | 12,509 | $603K |
| GEHCGE HealthCare Technologies Inc. | 8,449 | $601K |
| DGXQuest Diagnostics Incorporated | 3,059 | $600K |
| KRYSKrystal Biotech, Inc. | 2,115 | $546K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,639 | $542K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 25,670 | $475K |
| RPRXRoyalty Pharma plc | 9,560 | $459K |
| LQDALiquidia Corp | 12,105 | $457K |
| INCYIncyte Corp. | 4,851 | $457K |
| ARGXARGENX SE | 590 | $431K |
| NBIXNEUROCRINE BIOSCIENCES INC | 3,242 | $427K |
| HALOHALOZYME THERAPEUTICS, INC. | 6,262 | $405K |
| IQVIQVIA Holdings Inc. | 2,139 | $365K |
| UTHRUNITED THERAPEUTICS Corp | 566 | $336K |
| RCKTRocket Pharmaceuticals Inc. | 89,001 | $319K |
| ZBHZimmer Biomet Holdings Inc. | 3,510 | $317K |
| MIRMMirum Pharmaceuticals, Inc. | 3,324 | $307K |
| INVAInnoviva, Inc. | 12,967 | $302K |
| ELVElevance Health Inc. | 1,028 | $301K |
| TEVATeva Pharmaceutical Industries Limited | 9,919 | $299K |
| ARRYARRAY BIOPHARMA INC | 40,078 | $290K |
| ONCBeOne Medicines Ltd. | 906 | $269K |
| ARQTArcutis Biotherapeutics, Inc. | 10,584 | $249K |
| TBPHTheravance Biopharma, Inc. | 14,362 | $233K |
| ERASErasca, Inc. | 14,004 | $227K |
| PGNYProgyny Inc. | 12,498 | $212K |
| NTLAIntellia Therapeutics, Inc. | 16,256 | $208K |
| FOLDAMICUS THERAPEUTICS, INC. | 13,620 | $197K |
| ALHCAlignment Healthcare Inc. | 11,166 | $197K |
| VTRSViatris Inc | 13,930 | $188K |
| REPLReplimune Group, Inc. | 21,646 | $166K |
| PRTAPROTHENA CORP PUBLIC LTD CO | 16,793 | $163K |
| FDMT4D Molecular Therapeutics, Inc. | 16,359 | $152K |
| ABCLAbCellera Biologics Inc. | 19,305 | $67K |
| ALLOAllogene Therapeutics, Inc. | 14,870 | $36K |
| MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. | 10,253 | $29K |